Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA advisory committees

This article was originally published in The Tan Sheet

Executive Summary

Nonprescription Drugs Advisory Committee slated to meet March 6-7, June 13-14 and Sept. 16-17, according to 1tentative 2003 advisory committee schedule published in Dec. 19 Federal Register. NDAC considered Rx-to-OTC switch applications for Schering-Plough's Claritin (loratadine) and AstraZeneca/Procter & Gamble's Prilosec (omeprazole), and discussed labeling and marketing for acetaminophen, aspirin and NSAIDs in 2002. CFSAN's Dietary Supplements Subcommittee of the Food Advisory Committee is slated to meet March 27-28 and Sept. 22-23, while the parent committee is scheduled to convene Feb. 24-26 and Aug. 18-20...

You may also be interested in...



NDAC meetings rescheduled

Nonprescription Drugs Advisory Committee tentative meeting dates have been rescheduled for June 12-13 and Sept. 16-17. Dietary Supplements Subcommittee tentative meeting dates still slated for March 27-28 and Sept. 22-23, as reported in 1"The Tan Sheet" Dec. 23, 2002, In Brief...

Cipla Granted Approval For First US Proventil Rival

Shortly after wrapping up a Phase III trial for its proposed generic Advair Diskus product in the US, Cipla has won FDA approval for the first generic Proventil HFA product, as it continues to build up steam in the US respiratory market.

UK Publishes COVID-19 Self-Test Specifications

The UK's MHRA is looking for manufacturers to submit COVID-19 self-tests that meet minimum and desired criteria for evaluation, after finding its recently purchased 3.5m self-tests failed to meet these standards. Criteria include no requirement for testing knowledge or training or assistance from a healthcare professional in administering or interpreting the results of the test, as well as a 95% accuracy level. 

Topics

UsernamePublicRestriction

Register

PS094933

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel